Patent · US Active

Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers

US9730976B2 · kind B2 · utility

0Cited by
0References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 16, 2016
Grant dateAug 15, 2017
Priority date
Expiry dateMar 16, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to conformationally constrained homo- and heterodimeric mimetics of Smac with function as inhibitors of Inhibitor of Apoptosis Proteins (IAPs), the invention also relates to the use of these compounds in therapy, wherein the induction of apoptotic cell death is beneficial, especially in the treatment of cancer, alone or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.